Association between Perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: A cross-sectional study

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Wang, Yan ^a   Starling, Anne P ^a,b   Haug, Line S ^c   Eggesbo, Merete ^c   Becher, Georg ^c,d   Thomsen, Cathrine ^c   Travlos, Gregory ^a   King, Debra ^a   Hoppin, Jane A ^a   Rogan, Walter J ^a   Longnecker, Matthew P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

MoBa; Perfluorinated alkyl substances; Pregnant women; The Norwegian Mother and child cohort study; Thyroid stimulating hormone

Indexed keywords

ALKYL GROUP; INDUSTRIAL CHEMICAL; PERFLUOROALKYL DERIVATIVE; PERFLUOROBUTANOIC ACID; PERFLUORODECANOIC ACID; PERFLUORODODECANOIC ACID; PERFLUOROHEPTANE SULFONIC ACID; PERFLUOROHEPTANOIC ACID; PERFLUOROHEXANE SULFONIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANE SULFONAMIDE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROTETRADECANOIC ACID; PERFLUOROTRIDECANOIC ACID; PERFLUOROUNDECANOIC ACID; THYROTROPIN; UNCLASSIFIED DRUG; ALKANE; FLUOROCARBON; POLLUTANT;

COHORT ANALYSIS; CONCENTRATION (COMPOSITION); HORMONE; ORGANIC COMPOUND; POLLUTION EXPOSURE; PREGNANCY; WOMENS HEALTH;

ADULT; ARTICLE; ASSOCIATION; BLOOD SAMPLING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANT WOMAN; PRIORITY JOURNAL; SEA FOOD; SECOND TRIMESTER PREGNANCY; SMOKING; TANDEM MASS SPECTROMETRY; THYROTROPIN BLOOD LEVEL; ADOLESCENT; BLOOD; ENVIRONMENTAL MONITORING; IMMUNOASSAY; NORWAY; POLLUTANT; PREGNANCY; RISK; STATISTICAL MODEL; YOUNG ADULT;

NORWAY;

ADOLESCENT; ADULT; ALKANES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; IMMUNOASSAY; LINEAR MODELS; NORWAY; ODDS RATIO; PREGNANCY; TANDEM MASS SPECTROMETRY; THYROTROPIN; YOUNG ADULT;

EID: 84884308227     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-76     Document Type: Article

References (48)

1. Emerging food contaminants: a review. Kantiani L, Llorca M, Sanchís SJ, Farre M, Barcelo D, Environ Sci Technol 2010 398 2413 2427
2. Growing concern over perfluorinated chemicals. Renner R, Environ Sci Technol 2001 35 154A 160A 10.1021/es012317k 11348100 (Pubitemid 32862492)
3. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Johnson JD, Gibson SJ, Ober RE, Fundam Appl Toxicol 1984 4 972 976 10.1016/0272-0590(84)90235-5 6519377 (Pubitemid 15182587)
4. Global distribution of perfluorooctane sulfonate in wildlife. Giesy JP, Kannan K, Environ Sci Technol 2001 35 1339 1342 10.1021/es001834k 11348064 (Pubitemid 32862501)
5. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Fromme H, Schlummer M, Moller A, Gruber L, Wolz G, Ungewiss J, Bohmer S, Dekant W, Mayer R, Liebl B, Twardella D, Environ Sci Technol 2007 41 7928 7933 10.1021/es071244n 18075110 (Pubitemid 350133340)
6. Diet and particularly seafood are major sources of perfluorinated compounds in humans. Haug LS, Thomsen C, Brantsaeter AL, Kvalem HE, Haugen M, Becher G, Alexander J, Meltzer HM, Knutsen HK, Environ Int 2010 36 772 778 10.1016/j.envint.2010.05.016 20579735
7. Characterisation of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Haug LS, Huber S, Becher G, Thomsen C, Environ Int 2011 37 687 693 10.1016/j.envint.2011. 01.011 21334069
8. Endocrine disrupting properties of perfluorooctanoic acid. White SS, Fenton SE, Hines EP, J Steroid Biochem Mol Biol 2011 127 16 26 10.1016/j.jsbmb.2011.03.011 21397692
9. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. Contempre B, Jauniaux E, Calvo R, Jurkovic D, Campbell S, de Escobar GM, J Clin Endocrinol Metab 1993 77 1719 1722 10.1210/jc.77.6.1719 8263162 (Pubitemid 24000941)
10. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. Vulsma T, Gons MH, de Vijlder JJ, N Engl J Med 1989 321 13 16 10.1056/NEJM198907063210103 2733742 (Pubitemid 19170379)
11. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Fisher DA, Clin Obstet Gynecol 1997 40 16 31 10.1097/00003081- 199703000-00005 9103947 (Pubitemid 27152436)
12. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Idris I, Srinivasan R, Simm A, Page RC, Clin Endocrinol (Oxf) 2005 63 560 565 10.1111/j.1365-2265.2005.02382.x (Pubitemid 41626752)
13. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M, Arch Gynecol Obstet 2010 281 215 220 10.1007/s00404-009-1105-1 19437026
14. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL, Toxicology 2008 243 330 339 10.1016/j.tox.2007.10.014 18063289 (Pubitemid 50008113)
15. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K + PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression. Butenhoff JL, Stump DG, Parker GA, Wallace KB, Bjork JA, Ehresman DJ, Chang SC, Reproductive toxicology (Elmsford, N.Y) 2009 27 387 399 10.1016/j.reprotox.2009.01.005
16. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA, Toxicol Sci 2003 74 382 392 10.1093/toxsci/kfg122 12773772 (Pubitemid 36958307)
17. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C, Toxicol Sci 2003 74 369 381 10.1093/toxsci/kfg121 12773773 (Pubitemid 36958306)
18. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM, J Toxicol Sci 2011 36 403 410 10.2131/jts.36.403 21804304
19. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P, Environ Health Perspect 2009 117 1380 1386 19750101
20. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SH, Chien KL, Liao CC, Sung FC, Chen PC, Su TC, J Hazard Mater 2013 244-245 637 644 23314003
21. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS, Environ Health Perspect 2010 118 686 692 10.1289/ehp.0901584 20089479
22. Exploratory assessment of perfluorinated compounds and human thyroid function. Bloom MS, Kannan K, Spliethoff HM, Tao L, Aldous KM, Vena JE, Physiol Behav 2010 99 240 245 10.1016/j.physbeh.2009.02.005 19419669
23. Perfluorinated acids and hypothyroxinemia in pregnant women. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW, Environ Res 2011 111 559 564 10.1016/j.envres.2011.01.011 21310403
24. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM, J Occup Environ Med 2006 48 771 779 10.1097/01.jom.0000233380.13087.37 16902369 (Pubitemid 44221831)
25. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, Kim S, Park S, Hwang I, Jeon J, Yang H, Giesy JP, Environ Sci Technol 2011 45 7465 7472 10.1021/es202408a 21805959
26. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C, Int J Epidemiol 2006 35 1146 1150 10.1093/ije/dyl170 16926217 (Pubitemid 44605528)
27. Perfluorinated compounds and subfecundity in pregnant women. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Longnecker MP, Epidemiology (Cambridge, Mass) 2012 23 257 263 10.1097/EDE.0b013e31823b5031
28. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Ronningen KS, Paltiel L, Meltzer HM, Nordhagen R, Lie KK, Hovengen R, Haugen M, Nystad W, Magnus P, Hoppin JA, Eur J Epidemiol 2006 21 619 625 10.1007/s10654-006-9041-x 17031521 (Pubitemid 44546625)
29. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. Haug LS, Thomsen C, Becher G, J Chromatogr A 2009 1216 385 393 10.1016/j.chroma.2008.10. 113 19026423
30. Analyses of case-control data for additional outcomes. Weiland SK, Klenk J, Rzehak P, Richardson DB, Epidemiology (Cambridge, Mass) 2007 18 441 445 10.1097/EDE.0b013e318060d25c (Pubitemid 46955309)
31. Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Pearce EN, Oken E, Gillman MW, Lee SL, Magnani B, Platek D, Braverman LE, Endocr Pract 2008 14 33 39 10.4158/EP.14.1.33 18238739
32. The effects of PCB exposure and fish consumption on endogenous hormones. Persky V, Turyk M, Anderson HA, Hanrahan LP, Falk C, Steenport DN, Chatterton R Jr, Freels S, Environ Health Perspect 2001 109 1275 1283 10.1289/ehp.011091275 11748036 (Pubitemid 34055917)
33. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? del Escobar Rey F, Obregon MJ, de Morreale Escobar G, J Clin Endocrinol Metab 2000 85 3975 3987 10.1210/jc.85.11.3975 11095417 (Pubitemid 32055337)
34. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Yu WG, Liu W, Jin YH, Environ Toxicol Chem 2009 28 990 996 10.1897/08-345.1 19045937
35. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Weiss JM, Andersson PL, Lamoree MH, Leonards PE, van Leeuwen SP, Hamers T, Toxicol Sci 2009 109 206 216 10.1093/toxsci/kfp055 19293372
36. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Mandel SJ, Spencer CA, Hollowell JG, Thyroid 2005 15 44 53 10.1089/thy.2005.15.44 15687823 (Pubitemid 40223500)
37. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Fei C, Olsen J, Environ Health Perspect 2011 119 573 578 21062688
38. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, Marcus M, Environ Health Perspect 2012 120 1432 1437 22935244
39. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ, Thyroid 2004 14 1084 1090 10.1089/thy.2004.14. 1084 15650363 (Pubitemid 40076135)
40. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Soldin OP, Soldin D, Sastoque M, Ther Drug Monit 2007 29 553 559 10.1097/FTD.0b013e31815709ac 17898643 (Pubitemid 47494051)
41. Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine. Silvio R, Swapp KJ, La'ulu SL, Hansen-Suchy K, Roberts WL, Clin Biochem 2009 42 750 753 10.1016/j.clinbiochem. 2008.12.004 19124013
42. The disorders induced by iodine deficiency. Delange F, Thyroid 1994 4 107 128 10.1089/thy.1994.4.107 8054857 (Pubitemid 24145895)
43. Incidence and risk factors of fetal death in Norway: a case-control study. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM, Acta obstetricia et gynecologica Scandinavica 2011 90 390 397 10.1111/j.1600-0412.2011.01079.x 21306337
44. Thyroid function and human reproductive health. Krassas GE, Poppe K, Glinoer D, Endocr Rev 2010 31 702 755 10.1210/er.2009-0041 20573783
45. Utiger RD, The thyroid: a fundamental and clinical text Philadelphia: JB Lippincott 1986
46. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Asvold BO, Bjoro T, Vatten LJ, Eur J Endocrinol 2011 164 101 105 10.1530/EJE-10-0705 20930062
47. Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, 3rd Clewell HJ, J Environ Sci Health [A]: Current, Issues 2013 76 25 57 10.1080/15287394.2012.722523
48. Self-selection and bias in a large prospective pregnancy cohort in Norway. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P, Paediatr Perinat Epidemiol 2009 23 597 608 10.1111/j.1365-3016.2009.01062.x 19840297